Characteristics of 'super responders' and 'super nonresponders' to first biologic monotherapy for psoriasis: a nested case–control study.

MLA

Mason, Kayleigh J., et al. “Characteristics of ‘Super Responders’ and ‘Super Nonresponders’ to First Biologic Monotherapy for Psoriasis: A Nested Case–control Study.” British Journal of Dermatology, vol. 190, no. 3, Mar. 2024, pp. 441–44. EBSCOhost, https://doi.org/10.1093/bjd/ljad446.

APA

Mason, K. J., Alabas, O. A., Dand, N., Warren, R. B., Reynolds, N. J., Barker, J. N. W. N., Yiu, Z. Z. N., Smith, C. H., Griffiths, C. E. M., & Group, the B. S. (2024). Characteristics of “super responders” and “super nonresponders” to first biologic monotherapy for psoriasis: a nested case–control study. British Journal of Dermatology, 190(3), 441–444. https://doi.org/10.1093/bjd/ljad446

Chicago

Mason, Kayleigh J, Oras A Alabas, Nick Dand, Richard B Warren, Nick J Reynolds, Jonathan N W N Barker, Zenas Z N Yiu, Catherine H Smith, Christopher E M Griffiths, and the BADBIR Study Group. 2024. “Characteristics of ‘Super Responders’ and ‘Super Nonresponders’ to First Biologic Monotherapy for Psoriasis: A Nested Case–control Study.” British Journal of Dermatology 190 (3): 441–44. doi:10.1093/bjd/ljad446.